PAFAH (PLA2G7) (NM_001168357) Human Recombinant Protein

CAT#: TP700262

Purified recombinant protein of human phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (PLA2G7 / Lp-PLA2), transcript variant 2, with C-terminal DDK/His tag, expressed in human cells, 20 µg

Product Images

Specifications

Product Data

• Species: Human
• Expression Host: HEK293
• Expression cDNA Clone or AA Sequence:
  Protein Sequence

  A DNA sequence from TrueORF clone, RC230088, encoding the region (Phe22 – Asn441) of human PLA2G7
• Tag: C-DDK/His
• Predicted MW: 51 kDa
• Concentration: >50 ug/mL as determined by microplate BCA method
• Purity: > 80% as determined by SDS-PAGE and Coomassie blue staining
• Buffer: PBS, pH7.4, 10% glycerol
• Storage: Store at -80°C.
• Stability: Stable for 12 months from the date of receipt of the product under proper storage and handling conditions. Avoid repeated freeze-thaw cycles.

Reference Data

• RefSeq: NP_001161829
• Locus ID: 7941
• UniProt ID: Q13093
• Cytogenetics: 6p12.3
• Refseq ORF: 1323
• Synonyms: LDL-PLA2; LP-PLA2; PAFAD; PAFAH
• Summary: The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Dec 2009]
• Protein Families: Druggable Genome, Secreted Protein
• Protein Pathways: Ether lipid metabolism, Metabolic pathways